Clinical Trial Update: DOAC in Patients with Child a or B Liver Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a direct oral anticoagulant in patients with Child-Pugh A or B cirrhosis; study status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver

Drugs mentioned

• Direct Oral Anticoagulant (DOAC)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Liver Cirrhosis | Phase 2 | Status: RECRUITING